Citations

Showing 10 of 108135 citations.

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
Filippi, Massimo , Preziosa, Paolo , Banwell, Brenda , Barkhof, Frederik , Ciccarelli, Olga , Stefano, Nicola De , Geurts, Jeroen J.G. , Paul, Friedemann , Reich, Daniel S. , Toosy, Ahmed , Wattjes, Mike P. , Yousry, Tarek , Gass, Achim , Lubetzki, Catherine , Weinshenker, Brian G. , Rocca, Maria A. , Weinshenker, Brian G , Filippi, Massimo , Barkhof, Frederik , Paul, Friedemann , Rocca, Maria A , Ciccarelli, Olga , Traboulsee, Anthony

Mayo Clinic

Brain | May 13, 2019 | Volume: 142 | Issue: 7 | Pages: 1858-1875

10.1093/brain/awz144 | PMID 31209474 Get It

Abstract MRI has improved the diagnostic work-up of multiple sclerosis, but inappropriate image interpretation and application of MRI diagnostic criteria contribute to misdiagnosis. Some diseases, now recognized as conditions distinct from multiple sclerosis, may satisfy the MRI criteria for multiple sclerosis (e.g. neuromyelitis optica spectrum disorders, Susac syndrome), thus making the diagnosis of multiple sclerosis more challenging, especially if biomarker testing (such as serum anti-AQP4 antibodies) is not informative. Improvements in MRI technology contribute and promise to better define the typical features of multiple sclerosis lesions (e.g. juxtacortical and periventricular location, cortical involvement). Greater understanding of some key aspects of multiple sclerosis pathobiology has allowed the identification of characteristics more specific to multiple sclerosis (e.g. central vein sign, subpial demyelination and lesional rims), which are not included in the current multiple sclerosis diagnostic criteria. In this review, we provide the clinicians and researchers with a practical guide to enhance the proper recognition of multiple sclerosis lesions, including a thorough definition and illustration of typical MRI features, as well as a discussion of red flags suggestive of alternative diagnoses. We also discuss the possible place of emerging qualitative features of lesions which may become important in the near future.
Sonographic Identification of an Atypical Palmar Cutaneous Branch of the Median Nerve
Hoefler, Amanda Honsvall , Smith, Jay , Hoffman, Douglas F. , Honsvall Hoefler, Amanda

Mayo Clinic

PM&R | May 13, 2019 | Volume: 11 | Issue: 11 | Pages: 1248-1249

10.1002/pmrj.12188 | PMID 31081285 Get It

Update on the Prenatal Diagnosis and Outcomes of Fetal Bilateral Renal Agenesis
Huber, Carola , Blumenfeld, Yair J. , Jelin, Eric B. , Shazly, Sherif A. , Ruano, Rodrigo

Mayo Clinic

Obstetrical & Gynecological Survey | May 13, 2019 | Volume: 74 | Issue: 5 | Pages: 298-302

10.1097/ogx.0000000000000670 | PMID 31098643 Get It

Importance Bilateral renal agenesis is a rare congenital anomaly associated with poor prognosis. Objective The aims of this article are to review and summarize evidence on prenatal diagnosis and outcomes of bilateral renal agenesis. Evidence Acquisition A search was undertaken using PubMed and ClinicalTrials.gov databases from January 1, 1998, to September 1, 2018. Search terms include “prenatal diagnosis” OR “outcomes” AND “bilateral renal agenesis.” Search was limited to English language. Results Fetal ultrasonography is the primary imaging modality for prenatal diagnosis of fetal urogenital tract abnormalities. However, ultrasonography is limited by several factors; it is operator dependent and associated with small field of view, has limited soft-tissue acoustic contrast, and is also influenced by patient habitus and fetal position. Color Doppler ultrasonography can be used as an adjunct to exclude bilateral renal agenesis by visualizing renal arteries. In the literature, prenatal magnetic resonance imaging has been reported to be equal to or superior to prenatal ultrasonography. Bilateral renal agenesis with oligohydramnios/anhydramnios is associated with a poor prognosis; perinatal death occurs secondary to pulmonary hypoplasia in the majority of cases. Conclusions Ultrasonography in combination with color Doppler ultrasonography permits the fetal urinary tract to be assessed in the first and early second trimester of gestation. The magnetic resonance imaging can be used as a complementary adjunctive modality in equivocal or inconclusive ultrasonographic findings. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After completing this activity, the learner should be able to describe the natural history of fetuses with bilateral renal agenesis; explain to patients the accuracy and limitations of the prenatal diagnosis of the anomaly; and counsel patients regarding the perinatal outcome and prognosis of fetuses with this condition.
ENDOSCOPIC REMOVAL OF A MIGRATED ENDOSCOPIC DUODENOJEJUNAL BYPASS (ENDOBARRIER) WHICH HAD EMBEDDED ITS BARBWIRES INTO THE ANGLE OF TREITZ
Martinez-Alcala, A, Kroener, PT, D'Assunção, MA, Peter, Sudhir, Mönkemüller, Klaus, Martinez-Alcala, A, Peter, S

Mayo Clinic

Endoscopy | May 13, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1681765 Get It

ENDOSCOPIC SLEEVE PLICATION (ESP) FOR TREATMENT OF OBESITY I-II. PRELIMINARY RESULTS OF 2 SITES WITH THE NEW PATTERN FOR GASTRIC EMPTYING DELAY
Arau, Román Turró, Dayeh, B Abu, Nava, G, Ribera, M. Rosinach, Escudero, J Michelena, Koecklin, H Ikuo Uchima, Bilbao, Alfredo Mata , Homedes, J Turró, Pérez, JC Espinós, Koecklin, Hugo Uchima

Mayo Clinic

Endoscopy | May 13, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1681323 Get It

What Is New in Hysterectomy for Benign Gynecologic Disorders?
Famuyide, Abimbola O.

Mayo Clinic

Obstetrics & Gynecology | May 13, 2019 | Volume: 133 | Issue: 6 | Pages: 1278-1280

10.1097/aog.0000000000003294 | PMID 31135746 Get It

This month we focus on current research in hysterectomy for benign gynecologic disorders. Dr. Famuyide discusses four recent publications, which are concluded with a “bottom-line” that is the take-home message. A complete reference for each can be found on Box 1 on this page along with direct links to abstracts.
The Microbiome and the Gastrointestinal Interventionalist
Breen, Ilana, Hangge, Patrick T., Alzubaidi, Sadeer , Naidu, Sailendra , Knuttinen, Grace , Kriegshauser, J. Scott , Öklü, Rahmi

Mayo Clinic

Digestive Disease Interventions | May 13, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0039-1689019 Get It

Diabetic Gastroparesis
Bharucha, Adil E. , Kudva, Yogish C. , Prichard, David O.

Mayo Clinic

Endocrine Reviews | May 13, 2019 | Volume: 40 | Issue: 5 | Pages: 1318-1352

10.1210/er.2018-00161 | PMID 31081877 Get It

Abstract This review covers the epidemiology, pathophysiology, clinical features, diagnosis, and management of diabetic gastroparesis, and more broadly diabetic gastroenteropathy, which encompasses all the gastrointestinal manifestations of diabetes mellitus. Up to 50% of patients with type 1 and type 2 DM and suboptimal glycemic control have delayed gastric emptying (GE), which can be documented with scintigraphy, 13C breath tests, or a wireless motility capsule; the remainder have normal or rapid GE. Many patients with delayed GE are asymptomatic; others have dyspepsia (i.e., mild to moderate indigestion, with or without a mild delay in GE) or gastroparesis, which is a syndrome characterized by moderate to severe upper gastrointestinal symptoms and delayed GE that suggest, but are not accompanied by, gastric outlet obstruction. Gastroparesis can markedly impair quality of life, and up to 50% of patients have significant anxiety and/or depression. Often the distinction between dyspepsia and gastroparesis is based on clinical judgement rather than established criteria. Hyperglycemia, autonomic neuropathy, and enteric neuromuscular inflammation and injury are implicated in the pathogenesis of delayed GE. Alternatively, there are limited data to suggest that delayed GE may affect glycemic control. The management of diabetic gastroparesis is guided by the severity of symptoms, the magnitude of delayed GE, and the nutritional status. Initial options include dietary modifications, supplemental oral nutrition, and antiemetic and prokinetic medications. Patients with more severe symptoms may require a venting gastrostomy or jejunostomy and/or gastric electrical stimulation. Promising newer therapeutic approaches include ghrelin receptor agonists and selective 5-hydroxytryptamine receptor agonists.
Ulnar-Sided Wrist Pain
Brogan, David M. , Berger, Richard A. , Kakar, Sanjeev , Kakar, Sanjeev

Mayo Clinic

JBJS Reviews | May 13, 2019 | Volume: 7 | Issue: 5 | Pages: e1-e1

10.2106/jbjs.rvw.17.00207 | PMID 31082935 Get It

» Ulnar-sided wrist pain encompasses a variety of pathologies including arthritis, tendinopathy, ligament injuries, and instability. » A careful physical examination can narrow the differential diagnosis, and adjunctive imaging may prove useful to confirm clinical suspicion. » The mainstay of nonoperative treatment is immobilization, hand therapy, and corticosteroid injections; surgical intervention is dictated by the specific pathology identified, recognizing that multiple pain generators may be present. » In the absence of distal radioulnar joint instability, when indicated, peripheral capsular repair of the triangular fibrocartilage complex may be an effective procedure for relieving pain. If instability is noted, foveal repair is advocated to restore stability. » Treatment of distal radioulnar joint arthritis continues to evolve as new implants and techniques emerge. » Ulnar shortening osteotomy, when indicated, can be a reliable surgical option to reduce pain and improve function.
Endoscopic Bariatric Therapy: A Guide to the Intragastric Balloon
Bazerbachi, Fateh , Vargas, Eric J. , Dayyeh, Barham K. Abu , Abu Dayyeh, Barham K

Mayo Clinic

American Journal of Gastroenterology | May 13, 2019 | Volume: 114 | Issue: 9 | Pages: 1421-1431

10.14309/ajg.0000000000000239 | PMID 31082868 Get It

Intragastric balloons (IGBs) are the most widely available endoscopic bariatric therapy for class I and II obesity in the United States. Although simple in application and reversible by nature, these devices may help patients initiate the important first steps in weight loss maintenance, provided that parallel efforts are in motion to prevent weight recidivism. Too often, therapeutic nihilism stems from unrealistic expectations of a given therapy. In the case of IGBs, this sentiment may occur when these interventions are applied in a vacuum and not within the purview of a multidisciplinary program that actively involves dieticians, endocrinologists, gastroenterologists, and surgeons. There is a clear and present need to apply different tactics in the remissive strategy to control the obesity pandemic, more so in a struggling landscape of an ever-widening gap in bridging interventions. With such demand, the IGB is an available tool that could be helpful when correctly implemented. In this exposition, we summarize the current state of IGBs available worldwide, discuss their mechanism of action, relay evidence for their short- and long-term efficacy, address safety profile concerns, and suggest procedural considerations in the real-world quotidian application.